31 March 2022
Our CAR T-cell Research Team talks to Claire Concannon from RNZ's Our Changing World about how we're building the future of cancer treatment in New Zealand.
Dr Patricia Rubio-Reyes, PhD Student Yasmin Nouri and Dr Rachel Perret are part of the Malaghan Institute's Freemasons CAR T-cell Research Programme. Their work, running in parallel to the Institute's CAR T-cell clinical trial, aims to both better understand this groundbreaking therapy at the molecular level, as well as develop ways to improve its safety and widen the scope of the therapy to treat more cancers in the future.
Related articles
Funding boost to improve lung cancer treatment outcomes in Aotearoa New Zealand
5 September 2025
Read more
Cancer, measles and allergic disease research funded in latest HRC grants round
19 August 2025
Read more
Malaghan cancer research double finalists in KiwiNet Research Commercialisation awards
7 August 2025
Read more
Horizontal mitochondria transfer: 10 years on from a groundbreaking discovery
7 May 2025
Read more
Kjesten Wiig: bringing life-changing treatments to life
27 February 2025
Read more
Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
13 February 2025
Read more